MedTrace Logo

Analgesic Control Following Knee Arthroscopy

NCT01169389 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 98

Last updated 2010-07-30

No results posted yet for this study

Summary

This study aims to investigate the analgesic effects offered by bupivacaine and Durolane (a hyaluronic acid supplement) administered immediately following the completion of knee arthroscopy.

Conditions

  • Knee
  • Arthroscopy
  • Analgesia

Interventions

PROCEDURE

Intraarticular injection

Durolane, one vial

PROCEDURE

Intra-articular injection of 0.5% Bupivacaine

Sponsors & Collaborators

  • Orthopaedic Research and Innovation Foundation, Ireland

    lead OTHER

Principal Investigators

  • Kevin J Mulhall, FRCSI · Orthopaedic Research and Innovation Foundation, Ireland

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-01-31
Primary Completion
2009-04-30
Completion
2009-06-30

Countries

  • Ireland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01169389 on ClinicalTrials.gov